The surgical sealants & adhesives market was valued at $2699.2 million in 2020, and is estimated to reach $5,165.2 million by 2030, growing at a CAGR of 6.7% from 2021 to 2030. Surgical sealant is a device, which is used during surgery to avoid prevent surgical complications such as air and fluid leaks. Surgical sealants and & adhesives are available in the form of films and foams, and aid which help by creating a hemostatic layer, which that stops the blood and air leakage from the targeted area.
The growth of the global surgical sealants & adhesives market is majorly driven by the alarming increase in the number of surgeries, rise in government initiatives for the development of the pharmaceutical and & medical device industry, and an increase in the number of approvals for surgical sealant products. In addition, as per the statistics provided by the American Society of Plastic Surgeons, in 2019, approximately 1.8 million cases of cosmetic minimally- invasive surgeries were performed in the U.S. The rise in demand for surgical procedures and surge increase in the usage of surgical sealants and & adhesives product drives the market growth. Moreover, as per the American Cancer Society Statistics 2021, in the U.S., there were about 44,280 new cases of thyroid cancer, out of which 12,150 were in men and 32,130 in women. Furthermore, as per the Organization for Economic Co-operation and Development, in 2018, there were 45,307 cases of coronary artery bypass grafting procedures were performed in Germany Hence, the increasing increase in incidences of emergency surgeries, and extensive surge in uses of surgical sealants & adhesives propels the growth of the market
An increase in government support for the management of Hashimoto’s thyroiditis and a surge in demand for effective treatment are the major factors that drive the global surgical sealants & adhesives market. In addition, the key players Baxter International and Integra Life Sciences, which provide numerous surgical sealants & adhesives products contribute toward the market growth. The rise in demand for surgical sealants & adhesives during surgical procedures act as a key driving force for the expansion of the global market.
Cardiovascular diseases (CVDs) are the leading cause of death globally across the globe, and it takes an estimate of 17.9 million lives fatalities each year. According to a report by the British Heart Foundation, in 2021, 7.6 million people live with were diagnosed with heart & circulatory diseases, and it causes causing about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart & blood vessels and include coronary heart disease, cerebrovascular disease, and rheumatic heart disease, and other conditions. Thus, the rise in the use of surgical sealants & adhesives during cardiac surgeries is expected to contribute to the growth of the surgical sealants & adhesives market.
However, the high cost associated with surgical sealants and the availability of replacements for surgical adhesives and & sealants hinder the growth of this market. For instance, minimally invasive surgeries surgery is an alternative, as this procedure only needs a small incision for the operation to be performed, thus eliminating the complications associated with bleeding and air leakage. Conversely, the introduction of novel surgical sealants and & adhesives is expected to create lucrative opportunities for the market.
The global surgical sealants and & adhesives market is segmented based on the basis of product, indication, application, and region. On the basis of the product, the market is bifurcated into natural/biological sealants & adhesives and synthetic /& semisynthetic sealants and & adhesives. Natural/biological sealants and &adhesives are further classified by Type and by origin.
According to type, natural/biological sealants and & adhesives are segmented into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and & adhesives are classified into fibrin-based, collagen-based, based, and albumin-based. Polysaccharide-based sealants and & adhesives are further classified into chitosan-based and other polysaccharide-based. BY As per origin, natural/biological sealants and & adhesives are divided fragmented into animal-based, human-based, and plant-based. Synthetic and semisynthetic sealants and & adhesives are further segmented into cyanoacrylates, polyethene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication, it is fragmented into surgical hemostasis & tissue sealing and tissue engineering. According to applications application, it is segmented into covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopaedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global surgical sealants & adhesives market are Baxter International Inc., B.Braun Melsungen AG, Becton Dickinson & Company, Cryolife Inc., CSL Ltd., Johnson & Johnson, Integra Life Sciences, Occular Therapeutix Inc., Sanofi, and Sealeantis.
The growth of the global surgical sealants & adhesives market is majorly driven by the alarming increase in the number of surgeries, rise in government initiatives for the development of the pharmaceutical and & medical device industry, and an increase in the number of approvals for surgical sealant products. In addition, as per the statistics provided by the American Society of Plastic Surgeons, in 2019, approximately 1.8 million cases of cosmetic minimally- invasive surgeries were performed in the U.S. The rise in demand for surgical procedures and surge increase in the usage of surgical sealants and & adhesives product drives the market growth. Moreover, as per the American Cancer Society Statistics 2021, in the U.S., there were about 44,280 new cases of thyroid cancer, out of which 12,150 were in men and 32,130 in women. Furthermore, as per the Organization for Economic Co-operation and Development, in 2018, there were 45,307 cases of coronary artery bypass grafting procedures were performed in Germany Hence, the increasing increase in incidences of emergency surgeries, and extensive surge in uses of surgical sealants & adhesives propels the growth of the market
An increase in government support for the management of Hashimoto’s thyroiditis and a surge in demand for effective treatment are the major factors that drive the global surgical sealants & adhesives market. In addition, the key players Baxter International and Integra Life Sciences, which provide numerous surgical sealants & adhesives products contribute toward the market growth. The rise in demand for surgical sealants & adhesives during surgical procedures act as a key driving force for the expansion of the global market.
Cardiovascular diseases (CVDs) are the leading cause of death globally across the globe, and it takes an estimate of 17.9 million lives fatalities each year. According to a report by the British Heart Foundation, in 2021, 7.6 million people live with were diagnosed with heart & circulatory diseases, and it causes causing about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart & blood vessels and include coronary heart disease, cerebrovascular disease, and rheumatic heart disease, and other conditions. Thus, the rise in the use of surgical sealants & adhesives during cardiac surgeries is expected to contribute to the growth of the surgical sealants & adhesives market.
However, the high cost associated with surgical sealants and the availability of replacements for surgical adhesives and & sealants hinder the growth of this market. For instance, minimally invasive surgeries surgery is an alternative, as this procedure only needs a small incision for the operation to be performed, thus eliminating the complications associated with bleeding and air leakage. Conversely, the introduction of novel surgical sealants and & adhesives is expected to create lucrative opportunities for the market.
The global surgical sealants and & adhesives market is segmented based on the basis of product, indication, application, and region. On the basis of the product, the market is bifurcated into natural/biological sealants & adhesives and synthetic /& semisynthetic sealants and & adhesives. Natural/biological sealants and &adhesives are further classified by Type and by origin.
According to type, natural/biological sealants and & adhesives are segmented into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and & adhesives are classified into fibrin-based, collagen-based, based, and albumin-based. Polysaccharide-based sealants and & adhesives are further classified into chitosan-based and other polysaccharide-based. BY As per origin, natural/biological sealants and & adhesives are divided fragmented into animal-based, human-based, and plant-based. Synthetic and semisynthetic sealants and & adhesives are further segmented into cyanoacrylates, polyethene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication, it is fragmented into surgical hemostasis & tissue sealing and tissue engineering. According to applications application, it is segmented into covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopaedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global surgical sealants & adhesives market are Baxter International Inc., B.Braun Melsungen AG, Becton Dickinson & Company, Cryolife Inc., CSL Ltd., Johnson & Johnson, Integra Life Sciences, Occular Therapeutix Inc., Sanofi, and Sealeantis.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global surgical sealants & adhesives market to identify the prevailing opportunities
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies
- Comprehensive analysis of factors that drive and restrict the market growth is provided
- Region- & country-wise analysis is provided to understand the market trends and dynamics
KEY MARKET SEGMENT
By Product:
- Natural/Biological Sealants and Adhesives
By Type
- Polypeptide/Protein-based Sealants and Adhesives
- Fibrin- Basedbased
- Collagen-Based
- Gelatin Gelatin-Basedbased
- Albumin- Basedbased
- Polysaccharide-based Sealants and Adhesives
- Chitosan- Basedbased
- Other Polysaccharide- Basedbased
By Origin
- Human Blood- Basedbased
- Animal- Basedbased
- Plant- Basedbased
- Synthetic and Semisynthetic Sealants and & Adhesives
- Cyanoacrylates
- Polyethylene Glycol-based Hydrogel
- Urethane-based Adhesives
- Other Synthetic Sealants and Adhesives
By Indication
- Tissue Sealing and & Hemostasis
- Tissue Engineering
By Application
- Central Nervous System (CNS) Surgeries
- General Surgeries
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Cosmetic Surgeries
- Ophthalmic Surgeries
- Urological Surgeries
- Pulmonary Surgeries
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- BBraun Melsungen AG
- Baxter InteranationalInternational Inc
- Becton Dickinson and Company
- Cryolife Inc
- CSL Ltd
- Johnson & Johnson
- Integra Life Sciences
- Ocular Therapeutix Inc
- Sanofi
- Sealeantis
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Surgical Sealants and Adhesives Market, by Product
Chapter 5: Surgical Sealants and Adhesives Market, by Application
Chapter 6: Surgical Sealants and Adhesives Market, by Indication
Chapter 7: Surgical Sealants and Adhesives Market, by Region
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Surgical Sealants and Adhesives Market, by Product
Chapter 5: Surgical Sealants and Adhesives Market, by Application
Chapter 6: Surgical Sealants and Adhesives Market, by Indication
Chapter 7: Surgical Sealants and Adhesives Market, by Region
Chapter 8: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Surgical Sealants and Adhesives Market by Product Type, Indication, and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030, the Surgical Sealants and Adhesives Market size was valued at $5,165.2 million by 2030, growing at a CAGR of 6.7% from 2021 to 2030.Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techniques. These products can be used as adjuncts to sutures to prevent air and liquid leakages. They can be developed naturally or synthetically, and are used to generate three-dimensional networks, which bind to the target tissues and act as sealants, hemostats, or adhesives. On an average, almost 114 million surgical and procedure-based wounds occur annually across the globe.
Factors that drive the growth of the global Surgical Sealants and Adhesives Market include increase in number of cardiac surgeries and rise in concerns to decrease surgical injuries. Furthermore, as per the iData Research, approximately 13 million laparoscopic surgeries are performed globally every year. Further, the FDA aims to enhance availability of appropriate, reliable, and accurate surgical sealants & adhesives to meet public health needs and increase access to treatments for consumers.
Moreover, the development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the Surgical Sealants and Adhesives Market. In addition, increase in demand for performing surgeries led to development of innovative instruments in the healthcare sector, thereby propelling growth of the market.
Moreover, initiatives taken by governments for development of surgical products and healthcare sector for manufacturing of surgical sealants & adhesives are the key factors that boost the growth of the market. Furthermore, surge in geriatric population, who are more vulnerable to chronic and cardiovascular disease led to increase in number of surgeries propel the growth of the surgical sealants and adhesives market.
Surgery is known as the best cure for various types of diseases. The prevalence of cardiovascular diseases in China has been increasing continuously. As per the report published in the Journal of Geriatric Cardiology by Li-Yuan Ma, in China, in 2020, over 290 million individuals suffered from cardiovascular diseases and nearly 2 out of every 5 fatalities occurred as a result of CVD . Therefore, rise in number of cardiovascular diseases results in increase in number of surgeries. This has led to increase in usage of surgical sealants & adhesives that boosts the growth of the market. Geriatric population is at high risk of suffering from cardiovascular diseases, increasing the demand for surgical interventions. Thus, rise in geriatric population is expected to drive the substantial growth of the surgical sealants and adhesives market during forecast period.
The global Surgical Sealants and Adhesives Market is segmented on the basis of type, usage, material, end user, and region. On the basis of type, the market is divided into hemostat clamps, aortic vascular clamps, bulldog forceps, needle holder, and others. The hemostat clamps segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number of cardiac surgeries, advancements in R&D activities in pharmaceutical & medical device industries, and surge in adoption of surgical sealants & adhesives instruments.
Depending on product, the market is bifurcated into natural/biological sealants & adhesives and synthetic/semisynthetic sealants & adhesives. Natural/biological sealants & adhesives segment is classified into type and origin. According to indication, the market is fragmented into surgical hemostasis & tissue sealing and tissue engineering. As per application it is categorized into central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the surgical sealants and adhesives market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, North America accounted for a majority of the global Surgical Sealants and Adhesives Market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of cardiovascular surgeries, increase in number of approvals for surgical sealants, presence of key players, and development in technology for healthcare. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in laparoscopic surgeries, rise in number of geriatric populations, growth in healthcare expenditures, and rise in adoption of surgical sealants & adhesives product.
Key Findings Of The Study
- By type, the natural biological sealants & adhesives segment was the highest contributor to the market in 2020
- On the basis of indication, the tissue sealing & hemostasis dominated the market in 2020, and is expected to continue this trend during the forecast period
- According to application, the cardiovascular surgeries segment dominated the surgical sealants and adhesives market in 2020, and is expected to continue this trend during the forecast period
Companies Mentioned
- Baxter International Inc.
- B.Braun Melsungen AG
- Becton Dickinson & Company
- Cryolife Inc., CSL Ltd.
- Johnson & Johnson
- Integra Life Sciences
- Occular Therapeutix Inc.
- Sanofi
- Sealeantis.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 314 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 2699.2 million |
| Forecasted Market Value ( USD | $ 5165.2 million |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
